Colorectal cancer: a tale of two sides or a continuum?

Mai Yamauchi, Paul Lochhead, Teppei Morikawa, Curtis Huttenhower, Andrew T Chan, Edward Giovannucci, Charles Fuchs, Shuji Ogino

Research output: Contribution to journalArticle

146 Citations (Scopus)

Abstract

Colorectal cancer comprises a heterogeneous group of diseases that arise through varying molecular carcinogenic pathways, involving complex interactions between tumour cells and the host microenvironment.1 2 It has long been appreciated that developmental and physiological differences exist between anatomic segments of the colorectum, and that colorectal cancers occur with distinctly different frequencies at different subsites.3 While approaches to surgical and adjuvant therapy have set rectal cancer as a separate entity, colon cancers still tend to get grouped together.

In the 1980s, epidemiological and molecular data suggested that cancers arising at different subsites may be biologically disparate, implying different cancer aetiologies or evolutions. These observations prompted the suggestion that the proximal and distal colon should be considered separately in aetiological studies, with the splenic flexure as a demarcation point.3 This dichotomisation has been propagated by subsequent clinical, translational and epidemiological studies,4–10 while evolving molecular data have galvanised and lent further support to the two-colon concept.11–14 It remains uncertain, however, whether the splenic flexure represents a genuine or arbitrary divide in the aetiological spectrum of colon cancers. Notably, our recent study,15 demonstrating that the frequencies of key tumour molecular features change gradually along the length of the colon (rather than abruptly at the splenic flexure), challenges the current two-colon paradigm. The aim of this article is to review data relevant to the current concept of distinct molecular pathogeneses for proximal versus distal colon cancers, to describe the impact of our recent findings and to discuss the implications for future research.

Original languageEnglish
Pages (from-to)794-797
Number of pages4
JournalGut
Volume61
Issue number6
DOIs
Publication statusPublished - 2012

Fingerprint

Transverse Colon
Colorectal Neoplasms
Colon
Colonic Neoplasms
Neoplasms
Rectal Neoplasms
Epidemiologic Studies
Therapeutics

Cite this

Yamauchi, M., Lochhead, P., Morikawa, T., Huttenhower, C., Chan, A. T., Giovannucci, E., ... Ogino, S. (2012). Colorectal cancer: a tale of two sides or a continuum? Gut, 61(6), 794-797. https://doi.org/10.1136/gutjnl-2012-302014

Colorectal cancer : a tale of two sides or a continuum? / Yamauchi, Mai; Lochhead, Paul; Morikawa, Teppei; Huttenhower, Curtis; Chan, Andrew T; Giovannucci, Edward; Fuchs, Charles; Ogino, Shuji.

In: Gut, Vol. 61, No. 6, 2012, p. 794-797.

Research output: Contribution to journalArticle

Yamauchi, M, Lochhead, P, Morikawa, T, Huttenhower, C, Chan, AT, Giovannucci, E, Fuchs, C & Ogino, S 2012, 'Colorectal cancer: a tale of two sides or a continuum?' Gut, vol. 61, no. 6, pp. 794-797. https://doi.org/10.1136/gutjnl-2012-302014
Yamauchi M, Lochhead P, Morikawa T, Huttenhower C, Chan AT, Giovannucci E et al. Colorectal cancer: a tale of two sides or a continuum? Gut. 2012;61(6):794-797. https://doi.org/10.1136/gutjnl-2012-302014
Yamauchi, Mai ; Lochhead, Paul ; Morikawa, Teppei ; Huttenhower, Curtis ; Chan, Andrew T ; Giovannucci, Edward ; Fuchs, Charles ; Ogino, Shuji. / Colorectal cancer : a tale of two sides or a continuum?. In: Gut. 2012 ; Vol. 61, No. 6. pp. 794-797.
@article{e25b6533694248fea383d9364a1b8141,
title = "Colorectal cancer: a tale of two sides or a continuum?",
abstract = "Colorectal cancer comprises a heterogeneous group of diseases that arise through varying molecular carcinogenic pathways, involving complex interactions between tumour cells and the host microenvironment.1 2 It has long been appreciated that developmental and physiological differences exist between anatomic segments of the colorectum, and that colorectal cancers occur with distinctly different frequencies at different subsites.3 While approaches to surgical and adjuvant therapy have set rectal cancer as a separate entity, colon cancers still tend to get grouped together. In the 1980s, epidemiological and molecular data suggested that cancers arising at different subsites may be biologically disparate, implying different cancer aetiologies or evolutions. These observations prompted the suggestion that the proximal and distal colon should be considered separately in aetiological studies, with the splenic flexure as a demarcation point.3 This dichotomisation has been propagated by subsequent clinical, translational and epidemiological studies,4–10 while evolving molecular data have galvanised and lent further support to the two-colon concept.11–14 It remains uncertain, however, whether the splenic flexure represents a genuine or arbitrary divide in the aetiological spectrum of colon cancers. Notably, our recent study,15 demonstrating that the frequencies of key tumour molecular features change gradually along the length of the colon (rather than abruptly at the splenic flexure), challenges the current two-colon paradigm. The aim of this article is to review data relevant to the current concept of distinct molecular pathogeneses for proximal versus distal colon cancers, to describe the impact of our recent findings and to discuss the implications for future research.",
author = "Mai Yamauchi and Paul Lochhead and Teppei Morikawa and Curtis Huttenhower and Chan, {Andrew T} and Edward Giovannucci and Charles Fuchs and Shuji Ogino",
note = "PMID: 22490520 [PubMed - indexed for MEDLINE] PMCID: PMC3345045 Free PMC Article",
year = "2012",
doi = "10.1136/gutjnl-2012-302014",
language = "English",
volume = "61",
pages = "794--797",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "6",

}

TY - JOUR

T1 - Colorectal cancer

T2 - a tale of two sides or a continuum?

AU - Yamauchi, Mai

AU - Lochhead, Paul

AU - Morikawa, Teppei

AU - Huttenhower, Curtis

AU - Chan, Andrew T

AU - Giovannucci, Edward

AU - Fuchs, Charles

AU - Ogino, Shuji

N1 - PMID: 22490520 [PubMed - indexed for MEDLINE] PMCID: PMC3345045 Free PMC Article

PY - 2012

Y1 - 2012

N2 - Colorectal cancer comprises a heterogeneous group of diseases that arise through varying molecular carcinogenic pathways, involving complex interactions between tumour cells and the host microenvironment.1 2 It has long been appreciated that developmental and physiological differences exist between anatomic segments of the colorectum, and that colorectal cancers occur with distinctly different frequencies at different subsites.3 While approaches to surgical and adjuvant therapy have set rectal cancer as a separate entity, colon cancers still tend to get grouped together. In the 1980s, epidemiological and molecular data suggested that cancers arising at different subsites may be biologically disparate, implying different cancer aetiologies or evolutions. These observations prompted the suggestion that the proximal and distal colon should be considered separately in aetiological studies, with the splenic flexure as a demarcation point.3 This dichotomisation has been propagated by subsequent clinical, translational and epidemiological studies,4–10 while evolving molecular data have galvanised and lent further support to the two-colon concept.11–14 It remains uncertain, however, whether the splenic flexure represents a genuine or arbitrary divide in the aetiological spectrum of colon cancers. Notably, our recent study,15 demonstrating that the frequencies of key tumour molecular features change gradually along the length of the colon (rather than abruptly at the splenic flexure), challenges the current two-colon paradigm. The aim of this article is to review data relevant to the current concept of distinct molecular pathogeneses for proximal versus distal colon cancers, to describe the impact of our recent findings and to discuss the implications for future research.

AB - Colorectal cancer comprises a heterogeneous group of diseases that arise through varying molecular carcinogenic pathways, involving complex interactions between tumour cells and the host microenvironment.1 2 It has long been appreciated that developmental and physiological differences exist between anatomic segments of the colorectum, and that colorectal cancers occur with distinctly different frequencies at different subsites.3 While approaches to surgical and adjuvant therapy have set rectal cancer as a separate entity, colon cancers still tend to get grouped together. In the 1980s, epidemiological and molecular data suggested that cancers arising at different subsites may be biologically disparate, implying different cancer aetiologies or evolutions. These observations prompted the suggestion that the proximal and distal colon should be considered separately in aetiological studies, with the splenic flexure as a demarcation point.3 This dichotomisation has been propagated by subsequent clinical, translational and epidemiological studies,4–10 while evolving molecular data have galvanised and lent further support to the two-colon concept.11–14 It remains uncertain, however, whether the splenic flexure represents a genuine or arbitrary divide in the aetiological spectrum of colon cancers. Notably, our recent study,15 demonstrating that the frequencies of key tumour molecular features change gradually along the length of the colon (rather than abruptly at the splenic flexure), challenges the current two-colon paradigm. The aim of this article is to review data relevant to the current concept of distinct molecular pathogeneses for proximal versus distal colon cancers, to describe the impact of our recent findings and to discuss the implications for future research.

U2 - 10.1136/gutjnl-2012-302014

DO - 10.1136/gutjnl-2012-302014

M3 - Article

VL - 61

SP - 794

EP - 797

JO - Gut

JF - Gut

SN - 0017-5749

IS - 6

ER -